Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

Table 1 The plasmids encoding selected 49 T. gondii antigenic proteins

ToxoDB^a name	Plasmid name	ToxoDB^a name	Plasmid name
TGME49_047370_4	pA1	TGME49_034360_1	pB4
TGME49_026020_8	pB1	TGME49_113440_1	pC4
TGME49_053730_9	pC1	TGME49_013390_6	pD4
TGME49_061020_40	pD1	TGME49_073130_2	pE4
TGME49_047390_4	pE1	TGME49_075490_12	pF4
TGME49_024710_6	pF1	TGME49_114850_1	pG4
TGME49_104950_2	pG1	TGME49_047540_5	pH 4
TGME49_086450_1	pH 1	TGME49_110780_1	pA5
TGME49_021710_4	pA2	TGME49_026110_8	pB5
TGME49_121520_3	pB2	TGME49_093000_2	pC5
TGME49_037880_1	pC2	TGME49_078100_1	pD5
TGME49_093730_6	pD2	TGME49_092280_1	pE5
TGME49_015980_1	pE2	TGME49_026380_1	pF5
TGME49_001840_1	pF2	TGME49_090680_8	pG5
TGME49_039440_1	pG2	TGME49_005360_17	pH 5
TGME49_019310_8	pH 2	TGME49_109590_1	pA6
TGME49_027280_1	pA3	TGME49_114500_1	pB6
TGME49_003310_1	pB3	TGME49_055180_14	pC6
TGME49_048540_4	pC3	TGME49_055180_7	pD6
TGME49_100120_9	pD3	TGME49_025340_13	pE6
TGME49_095650_3	pE3	TGME49_022370_1	pF6
TGME49_051630_2	pF3	TGME49_026510_1	pG6
TGME49_054720_1	pG3	TGME49_013390_5	pH 6
TGME49_005360_12	pH 3	TGME49_095700_1	pA7
TGME49_058660_1	pA4

^aToxoDB: http://www.toxodb.org/toxo/
Bold written plasmids are the antigens selected for hexavalent vaccine development

ISSN: 1471-2334